Last week, during Kidney Cancer Awareness Week (3–7 February 2025), the Cancer Research UK Cambridge Centre shone a light on research by the Urological Malignancies Virtual Institute. Through their social media channels and website they introduced their audience to some of our members driving progress in kidney and prostate cancer research, offering an inside look at their innovative approaches and commitment to transforming patient care. Here's a summary of what we highlighted last week.
Meet the researcher: Bill McGough
Meet Bill McGough, a PhD student who is using artificial intelligence to develop a model that could make kidney cancer screening more efficient and ultimately help save lives.
Meet the researchers: Filipa Reis and Holly Barber
Meet Filipa and Holly, researchers working on closely aligned PhD projects examining treatment mechanism and response in patients with prostate cancer.
Meet the researcher: Nikita Sushentsev
Meet Nikita Sushentsev, a Gates Scholar at the University of Cambridge, using metabolic MRI to transform prostate cancer diagnosis. His research aims to improve treatment decisions and help patients avoid invasive biopsies.
From lab to clinic: an introduction to translational research with Dr James Jones
Dr James Jones is a clinical researcher driving progress in kidney cancer care. From innovative trials to cutting-edge translational research, his work is shaping precision treatments to improve patient outcomes.
Highlights from our Urological Malignancies Virtual Institute symposium and launch
In September 2024, over 70 colleagues gathered at Christ's College for a day of visionary talks, inspiring flash presentations, and future-focused discussions. From AI in radiology to precision medicine, we explored the future of urological cancer research.
Fighting kidney cancer with Isaac Toleman
With kidney cancer rates increasing, new treatments are urgently needed. Learn how PhD student Isaac Toleman is using patient-derived organoids to test therapies and accelerate immunotherapy advances, bringing us closer to precision care.
Combining kidney and lung cancer screening helps identify tumours before symptoms develop
Can kidney cancer screening save lives? This groundbreaking research, led by Professor Grant Stewart, shows that screening for kidney cancer is acceptable to patients and can be cost-effective. Discover how this work could transform diagnosis and patient care. The screening trial was funded by Yorkshire Cancer Research.
Meet the researcher: Rebecca Wray
Meet Rebecca Wray: From dreaming of curing cancer to pursuing a PhD at the Cancer Research UK Cambridge Centre, she's investigating kidney cancer treatment response using artificial intelligence. By linking tumour biology to drug outcomes, Rebecca aims to improve decisions making in the clinic.
Impact of the Urological Malignancies Virtual Institute
Discover the progress and impact of the Urological Malignancies Virtual Institute in their latest report. From groundbreaking research to clinical innovation, see how we're advancing care for kidney and prostate cancer patients.
Comments